Sexually Transmitted Diseases among American Youth: Incidence and Prevalence Estimates, 2000

Perspectives on Sexual and Reproductive Health

Volumn 36, Issue 1, 2004, Pages 6-10

  Weinstock, Hillard ^a   Berman, Stuart ^a   Cates Jr , Willard ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY CONTROL; RELIABILITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; UNITED STATES; VERRUCA VULGARIS;

EID: 1342280969     PISSN: 15386341     EISSN: None     Source Type: Journal    
DOI: 10.1363/3600604     Document Type: Article

References (51)

1. Cates W, Jr., and American Social Health Association Panel, Estimates of the incidence and prevalence of sexually transmitted diseases in the United States, Sexually Transmitted Diseases, 1999, 26(Suppl. 4):S2-7.
2. Sonenstein FL et al., Changes in sexual behavior and condom use among teenaged males: 1988 to 1995, American Journal of Public Health, 1998, 88(6):956-959; Abma J et al., Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth, Vital and Health Statistics, 1997, Vol. 23, No. 19; and Laumann EO et al., National Health and Social Life Survey, 1992, Chicago and Ann Arbor, MI: National Opinion Research Center and Inter-University Consortium for Political and Social Research, 1995.
3. Sonenstein FL et al., Changes in sexual behavior and condom use among teenaged males: 1988 to 1995, American Journal of Public Health, 1998, 88(6):956-959; Abma J et al., Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth, Vital and Health Statistics, 1997, Vol. 23, No. 19; and Laumann EO et al., National Health and Social Life Survey, 1992, Chicago and Ann Arbor, MI: National Opinion Research Center and Inter-University Consortium for Political and Social Research, 1995.
4. Sonenstein FL et al., Changes in sexual behavior and condom use among teenaged males: 1988 to 1995, American Journal of Public Health, 1998, 88(6):956-959; Abma J et al., Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth, Vital and Health Statistics, 1997, Vol. 23, No. 19; and Laumann EO et al., National Health and Social Life Survey, 1992, Chicago and Ann Arbor, MI: National Opinion Research Center and Inter-University Consortium for Political and Social Research, 1995.
5. Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
6. Centers for Disease Control and Prevention (CDC), Sexually Transmitted Disease Surveillance, 2000, Atlanta: CDC, 2001.
7. Levine WC et al., Indirect estimation of chlamydia screening coverage using public health surveillance data, American Journal of Public Health, 2004 (forthcoming).
8. Groseclose SL et al., Estimated incidence and prevalence of genital Chlamydia trachomatis infection in the United States, 1996, Sexually Transmitted Diseases, 1999, 26(6):339-344.
9. CDC, Chlamydia Prevalence Monitoring Project Annual Report 2000: Sexually Transmitted Disease Surveillance 2000 Supplement, Atlanta: CDC, 2001.
10. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
11. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
12. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
13. CDC, 2001, op. cit. (see reference 4).
14. Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
15. CDC, 2001, op. cit. (see reference 4).
16. I b i d.
17. Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
18. Johnson R et al., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, New England Journal of Medicine, 1989, 321(1):7-12; Fleming DT et al., Herpes simplex virus type 2 in the United States, 1976-1994, New England Journal of Medicine, 1997, 337(16):1105-1111; Armstrong G et al., Incidence of herpes simplex virus type 2 infection in the United States, American Journal of Epidemiology, 2001, 153(9):912-920; and Fisman DN et al., Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States, Sexually Transmitted Diseases, 2002, 29(10):608-622.
19. Johnson R et al., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, New England Journal of Medicine, 1989, 321(1):7-12; Fleming DT et al., Herpes simplex virus type 2 in the United States, 1976-1994, New England Journal of Medicine, 1997, 337(16):1105-1111; Armstrong G et al., Incidence of herpes simplex virus type 2 infection in the United States, American Journal of Epidemiology, 2001, 153(9):912-920; and Fisman DN et al., Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States, Sexually Transmitted Diseases, 2002, 29(10):608-622.
20. Johnson R et al., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, New England Journal of Medicine, 1989, 321(1):7-12; Fleming DT et al., Herpes simplex virus type 2 in the United States, 1976-1994, New England Journal of Medicine, 1997, 337(16):1105-1111; Armstrong G et al., Incidence of herpes simplex virus type 2 infection in the United States, American Journal of Epidemiology, 2001, 153(9):912-920; and Fisman DN et al., Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States, Sexually Transmitted Diseases, 2002, 29(10):608-622.
21. Johnson R et al., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, New England Journal of Medicine, 1989, 321(1):7-12; Fleming DT et al., Herpes simplex virus type 2 in the United States, 1976-1994, New England Journal of Medicine, 1997, 337(16):1105-1111; Armstrong G et al., Incidence of herpes simplex virus type 2 infection in the United States, American Journal of Epidemiology, 2001, 153(9):912-920; and Fisman DN et al., Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States, Sexually Transmitted Diseases, 2002, 29(10):608-622.
22. CDC, 2001, op. cit. (see reference 4).
23. Tao G, Kassler W and Rein D, Medical care expenditures for genital herpes in the United States, Sexually Transmitted Diseases, 2000, 27(1):32-38; and Corey L and Wald A, Genital herpes, in: Holmes KK et al., eds., Sexually Transmitted Diseases, New York: McGraw-Hill, 1999, pp. 285-312.
24. Tao G, Kassler W and Rein D, Medical care expenditures for genital herpes in the United States, Sexually Transmitted Diseases, 2000, 27(1):32-38; and Corey L and Wald A, Genital herpes, in: Holmes KK et al., eds., Sexually Transmitted Diseases, New York: McGraw-Hill, 1999, pp. 285-312.
25. Corey L and Handsfield H, Genital herpes and public health: addressing a global problem, Journal of the American Medical Association, 2000, 283(6):791-794.
26. Fleming DT et al., 1997, op. cit. (see reference 14).
27. Armstrong G et al., 2001, op. cit. (see reference 14).
28. I b i d.
29. Myers ER, Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis, American Journal Epidemiology, 2000, 151(12):1158-1171.
30. Bauer HM et al., Genital human papillomavirus infection in female university students as determined by a PCR-based method, Journal of the American Medical Association, 1991, 265(4):472-477.
31. Coleman PJ et al., Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys, Journal of Infectious Diseases, 1998, 178(4): 954-959.
32. Armstrong G, CDC, Atlanta, personal communication, Sept. 9, 2003.
33. Goldstein ST et al., Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs, Journal of Infectious Diseases, 2002, 185(6):713-719.
34. Margolis HS et al., Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations, Journal of the American Medical Association, 1995, 274(15):1201-1208.
35. World Health Organization (WHO), Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates, Geneva: WHO, 2001.
36. Krieger JN and Alderete JF, Trichomonas vaginalis and trichomoniasis, in: Holmes KK et al., 1999, op. cit. (see reference 16), pp. 587-604.
37. WHO, 2001, op. cit. (see reference 27).
38. Lossick JG, Epidemiology of urogenital trichomoniasis, in: Honigberg BM, ed., Trichomonads Parasitic in Humans, New York: Springer-Verlag, 1989, pp. 311-323; and Cotch MF et al., Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women, Obstetrics & Gynecology, 1991, 78(6):1087-1092.
39. Lossick JG, Epidemiology of urogenital trichomoniasis, in: Honigberg BM, ed., Trichomonads Parasitic in Humans, New York: Springer-Verlag, 1989, pp. 311-323; and Cotch MF et al., Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women, Obstetrics & Gynecology, 1991, 78(6):1087-1092.
40. Krieger JN and Alderete JF, 1999, op. cit. (see reference 28).
41. Karon JM et al., HIV in the United States at the turn of the century: an epidemic in transition, American Journal of Public Health, 2001, 91(7):1060-1068; and Karon JM et al., Prevalence of HIV infection in the United States, 1984 to 1992, Journal of the American Medical Association, 1996, 276(2):126-131.
42. Karon JM et al., HIV in the United States at the turn of the century: an epidemic in transition, American Journal of Public Health, 2001, 91(7):1060-1068; and Karon JM et al., Prevalence of HIV infection in the United States, 1984 to 1992, Journal of the American Medical Association, 1996, 276(2):126-131.
43. CDC, HIV among young men who have sex with men, Morbidity and Mortality Weekly Report, 2001, 50(21):440-444; and CDC, Primary and secondary syphilis-United States, 2002, Morbidity and Mortality Weekly Report, 2003, 52(46):1117-1120.
44. CDC, HIV among young men who have sex with men, Morbidity and Mortality Weekly Report, 2001, 50(21):440-444; and CDC, Primary and secondary syphilis-United States, 2002, Morbidity and Mortality Weekly Report, 2003, 52(46):1117-1120.
45. Rosenberg PS and Biggar RJ, Trends in HIV incidence among young adults in the United States, Journal of the American Medical Association, 1998, 279(23):1894-1899.
46. Doyle TJ, Glynn MK and Groseclose SL, Completeness of notifiable infectious disease reporting in the United States: an analytical review, American Journal of Epidemiology, 2002, 155(9):866-874.
47. Frost JJ, Public or private providers? U.S. women's use of reproductive health services, Family Planning Perspectives, 2001, 33(1):4-12.
48. Groseclose SL et al., 1999, op. cit. (see reference 6).
49. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
50. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
51. Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).